Home Other Building Blocks 978-62-1
978-62-1,MFCD00218820
Catalog No.:AA0036P9

978-62-1 | IMD-0354

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$11.00   $8.00
- +
5mg
98%
in stock  
$25.00   $18.00
- +
10mg
98%
in stock  
$37.00   $26.00
- +
50mg
98%
in stock  
$99.00   $69.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0036P9
Chemical Name:
IMD-0354
CAS Number:
978-62-1
Molecular Formula:
C15H8ClF6NO2
Molecular Weight:
383.6729
MDL Number:
MFCD00218820
SMILES:
Clc1ccc(c(c1)C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F)O
Properties
Properties
 
BP:
323.1°C at 760 mmHg  
Form:
Solid  
MP:
178-180°C  
Storage:
Keep in dry area;-20 ℃;  

Computed Properties
 
Complexity:
462  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
6.2  

Literature

Title: Central IKK2 Inhibition Ameliorates Air Pollution-Mediated Hepatic Glucose and Lipid Metabolism Dysfunction in Mice With Type II Diabetes.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20180701

Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.

Journal: Bioorganic & medicinal chemistry letters 20130801

Title: Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.

Journal: Bioorganic & medicinal chemistry 20130101

Title: Salicylanilide inhibitors of Toxoplasma gondii.

Journal: Journal of medicinal chemistry 20121011

Title: Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro.

Journal: Toxicology letters 20120307

Title: An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.

Journal: Cancer science 20120101

Title: Regulation of cytochrome P450 4F11 by nuclear transcription factor-κB.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20120101

Title: A novel IKK inhibitor prevents progression of restenosis after arterial injury in mice.

Journal: International heart journal 20120101

Title: Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats.

Journal: Molecular vision 20120101

Title: IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.

Journal: World journal of gastroenterology 20111221

Title: IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20110101

Title: Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-α via distinct NF-κB pathways in human nasal epithelial cells.

Journal: Toxicology and applied pharmacology 20110101

Title: A novel NF-κB inhibitor improves glucocorticoid sensitivity of canine neoplastic lymphoid cells by up-regulating expression of glucocorticoid receptors.

Journal: Research in veterinary science 20101201

Title: Copper activation of NF-kappaB signaling in HepG2 cells.

Journal: Journal of molecular biology 20091113

Title: Activation of host antiviral RNA-sensing factors necessary for herpes simplex virus type 1-activated transcription of host cell fucosyltransferase genes FUT3, FUT5, and FUT6 and subsequent expression of sLe(x) in virus-infected cells.

Journal: Glycobiology 20090701

Title: Antiallergic and anti-inflammatory effects of a novel I kappaB kinase beta inhibitor, IMD-0354, in a mouse model of allergic inflammation.

Journal: International archives of allergy and immunology 20090101

Title: NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.

Journal: Radiation research 20090101

Title: Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis.

Journal: Journal of gastroenterology 20090101

Title: Lipid-soluble smoke particles upregulate vascular smooth muscle ETB receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20081201

Title: Mechanism of signal transduction in tumor necrosis factor-like weak inducer of apoptosis-induced matrix degradation by MMP-3 upregulation in disc tissues.

Journal: Spine 20081101

Title: Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells.

Journal: Journal of medical and dental sciences 20080301

Title: Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms.

Journal: Journal of molecular and cellular cardiology 20070801

Title: Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC/NgaTnd mice.

Journal: The Journal of investigative dermatology 20070401

Title: Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction.

Journal: American journal of physiology. Heart and circulatory physiology 20070101

Title: Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone.

Journal: Modern rheumatology 20070101

Title: A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pulmonary fibrosis in mice.

Journal: American journal of respiratory and critical care medicine 20060501

Title: A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.

Journal: Cancer research 20060101

Title: A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors.

Journal: Blood 20050315

Title: A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance.

Journal: Biochemical and biophysical research communications 20041008

Title: Inhibition of the activation of nuclear factor kappa B to reduce myocardial reperfusion injury and infarct size.

Journal: Cardiovascular research 20040701

Title: Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury.

Journal: Cardiovascular research 20040701

Title: Tanaka A, et al. A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood. 2005 Mar 15;105(6):2324-31.

Title: Li YR, et al. Study of the inhibitory effects on TNF-α-induced NF-κB activation of IMD0354 analogs. Chem Biol Drug Des. 2017 Dec;90(6):1307-1311.

Title: Tanaka A, et al. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition. Cancer Res. 2006 Jan 1;66(1):419-26.

Title: Lennikov A, et al. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012;18:2586-97.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:978-62-1 Molecular Formula|978-62-1 MDL|978-62-1 SMILES|978-62-1 IMD-0354